Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lexeo Therapeutics, Inc. - Common Stock
(NQ:
LXEO
)
7.180
+0.280 (+4.06%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
799,869
Open
6.830
Bid (Size)
7.010 (2,500)
Ask (Size)
7.700 (100)
Prev. Close
6.900
Today's Range
6.780 - 7.235
52wk Range
1.450 - 10.99
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Keep an eye on the top gainers and losers in Monday's session.
↗
January 12, 2026
Via
Chartmill
Top stock movements in today's session.
↗
January 12, 2026
Via
Chartmill
Performance
YTD
-25.3%
-25.3%
1 Month
-5.2%
-5.2%
3 Month
-19.5%
-19.5%
6 Month
+49.9%
+49.9%
1 Year
+151.0%
+151.0%
More News
Read More
Gapping stocks in Monday's session
↗
January 12, 2026
Via
Chartmill
Lexeo Therapeutics Stock Hits 11-Month High On Bullish Analyst Calls For Friedreich’s Ataxia Gene Therapy — Retail Traders Join In
↗
October 08, 2025
Via
Stocktwits
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 07, 2025
Via
Benzinga
Lexeo Therapeutics Stock Rallies On Discussions With FDA To Expedite Friedreich’s Ataxia Drug Approval Process
↗
October 07, 2025
Via
Stocktwits
James Hardie Industries, AMD, Trilogy Metals, BTQ Technologies And Other Big Stocks Moving Higher On Tuesday
↗
October 07, 2025
Via
Benzinga
Tuesday's session: gap up and gap down stocks
↗
October 07, 2025
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
October 07, 2025
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
September 24, 2025
Via
Benzinga
FDA Outlines Process To Speed Up Rare Disease Therapy Approvals
↗
September 04, 2025
Via
Benzinga
Lexeo Reports Q2 Loss as Costs Jump 129%
↗
August 14, 2025
Via
The Motley Fool
Topics
Intellectual Property
This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday
↗
July 31, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 09, 2025
Via
Benzinga
Which stocks are moving on Monday?
↗
April 07, 2025
Via
Chartmill
Keep an eye on the top gainers and losers in Monday's session.
↗
April 07, 2025
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
April 07, 2025
Via
Benzinga
Monday's session: gap up and gap down stocks
↗
April 07, 2025
Via
Chartmill
Gene Therapy For Fatal Rare Disease-Associated Heart Condition - Lexeo Therapeutics Candidate Shows Improvements In Trials
↗
April 07, 2025
Via
Benzinga
Pharma Frenzy: Volatility Ignites Biotech Sector
March 25, 2025
Via
MarketBeat
Lexeo Therapeutics Sees Biggest Retail Follower Surge Among Biotech Stocks After Record-Breaking Rally: What's The Big Draw?
↗
March 25, 2025
Via
Stocktwits
What's going on in today's session
↗
March 24, 2025
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
March 24, 2025
Via
Benzinga
Traders are paying attention to the gapping stocks in Monday's session.
↗
March 24, 2025
Via
Chartmill
Frequently Asked Questions
Is Lexeo Therapeutics, Inc. - Common Stock publicly traded?
Yes, Lexeo Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Lexeo Therapeutics, Inc. - Common Stock trade on?
Lexeo Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lexeo Therapeutics, Inc. - Common Stock?
The ticker symbol for Lexeo Therapeutics, Inc. - Common Stock is LXEO on the Nasdaq Stock Market
What is the current price of Lexeo Therapeutics, Inc. - Common Stock?
The current price of Lexeo Therapeutics, Inc. - Common Stock is 7.180
When was Lexeo Therapeutics, Inc. - Common Stock last traded?
The last trade of Lexeo Therapeutics, Inc. - Common Stock was at 02/27/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
